🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

FTSE edges lower as pharmaceuticals weigh again

Published 26/08/2016, 10:17
© Reuters. A worker shelters from the rain as he passes the London Stock Exchange in the City of London
UK100
-
SOGN
-
SHP
-
BAES
-
CRH
-
RTN
-
MS
-
HG
-
FTNMX551030
-
GLEN
-

By Alistair Smout

LONDON (Reuters) - Britain's top share index edged lower on Friday, set to finish the week with falls as recent weakness in the pharmaceuticals continued, with investors wary over political risk in the sector.

By 0900 GMT, the FTSE 100 (FTSE) was down 4.20 points, or 0.1 percent, at 6,812.70, down 0.7 percent for the week and set for a second straight weekly fall.

Investors were awaiting a speech by Federal Reserve Chair Janet Yellen at a summit in Jackson Hole, due at 1400 GMT, before making strong bets on the market, traders said.

The pharmaceutical sector was the biggest drag on the index for a second straight day, trimming 6.7 points off the index.

It has been under pressure since U.S. Presidential candidate Hillary Clinton criticised the pricing of a high-profile drug.

Shire (L:SHP) fell 1.2 percent, but remains up 41.5 percent since lows in February. After a strong run, analysts said that the sector was now vulnerable.

"Investors are pulling funds from what now seems to be one of the most politically-sensitive industries in the run up to the US presidential election," said Jasper Lawler, market analyst at CMC Markets, in a note.

CRH (L:CRH) fell 0.9 percent, after posting a 2.9 percent rise following results on Thursday.

The building materials firm raised its dividend for the first time in 7 years, and many brokers lifted their target prices on the stock.

However, Societe Generale (PA:SOGN) cut its rating on the stock to "hold" from "buy".

"CRH reported a good set of numbers yesterday... But we believe the current stock price already factors in the medium term growth potential," analysts at SocGen said in a note.

BAE Systems (LON:BAES) rose 2.1 percent, benefiting from an upgrade by Berenberg.

Glencore (L:GLEN) bounced back from falls after results earlier this week. It was up 2.6 percent, the top FTSE 100 riser, but remained down for the week as a whole.

Copper prices also stabilised after falls this week, while the price of zinc hit a 15-month high. In all, miners (FTNMX1770) rose 1.5 percent.

The FTSE was unaffected by data showing that GDP was in-line with preliminary readings, and growth held up well ahead of Britain's decision to leave the European Union.

Among mid-caps, the Restaurant Group (L:RTN) rose 7 percent after beating expectations with results, while Amec Foster Wheeler rose 5.9 percent after an upgrade to "overweight" by Morgan Stanley (NYSE:MS).

© Reuters. A worker shelters from the rain as he passes the London Stock Exchange in the City of London

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.